Hjem › Kronisk myelomonocytisk leukæmi › Alabama
Kronisk myelomonocytisk leukæmi kliniske forsøg i Alabama
4 studier for Kronisk myelomonocytisk leukæmi søger deltagere på steder i Alabama.
Byer i Alabama
Officiel studietekst (engelsk)
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
- The University of Alabama at Birmingham, Birmingham
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07249346Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
- AllerVie Clinical Research, Birmingham
- O'Neal Comprehensive Cancer Center at the UAB, Birmingham
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT07143669A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- University of Alabama Birmingham, Birmingham
RekruttererFase 2
Alder 18 til 66 · Alle køn · Opdateret 17. mar. 2026 · NCT06859424Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- The Kirklin Clinic of UAB Hospital, Birmingham
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2025 · NCT03850574Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.